Filter By Unselect All
Sub Category Unselect See All
Country Unselect See All
Companies Unselect See All
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
Our catalog of well-characterized ELISAs, cell-based assays, and other biochemical screening assays are continuously used both in-house and by researchers worldwide to monitor biomarkers, assess cellular health, and measure enzyme activity/inhibition.
SCLS is Shantani's proprietary and most comprehensive method for target identification, validation and for determination of the mechanism of action.
The abundance of proteins in a sample of interest can vary by orders of magnitude, and often the most interesting proteins are present at very low levels. Discovery proteomics places high demands on separation, sensitivity, and informatics.
Proteome Sciences has developed an analytical proteomic pipeline to provide broad biological context of targets and drug mechanisms based on unbiased analysis of protein expression and phosphorylation (SysQuant®), statistical data modeling (FeaST) and a novel functional analysis tool (FAT).
Xcelris announces the launch of Proteomics services on advanced Bruker Autoflex MALDI-TOF platform. We offer advanced technical services which would help researchers for structural characterization of biomolecules such as proteins and peptides.
Precision Medicine requires close integration between targeted drugs and biomarkers providing early and actionable clinical information. Ideally, such biomarkers are mechanistically related to disease and treatment mechanisms, predictive of outcome and measurable in accessible samples, typically